• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

LexisNexis Risk Solutions Acquires Human API

Share:

May 2, 2023

LexisNexis Risk Solutions has acquired Human API, a proprietary consumer-driven data platform, to provide a next-generation consumer consent management solution for better access to healthcare data and insurance resources. The acquisition will enable more seamless delivery of data, and improve care coordination and automate life insurance underwriting. The financial details of the acquisition have not been disclosed.

What You Should Know:

– LexisNexis® Risk Solutions, part of RELX, today announced it has acquired Human API, a provider of a proprietary consumer-driven data platform.

– Together, LexisNexis Risk Solutions and Human API will deliver a next-generation consumer consent management solution that enables more seamless delivery of data. This approach empowers consumers with better access to their healthcare data and insurance resources that can improve care coordination and automate life insurance underwriting.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Financial details of the acquisition were not disclosed.

Source: hitConsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Flare Capital Partners Announces Close of Its Second Fund With $255 Million in CommitmentsFlare Capital Partners Announces Close of Its Second Fund With $255 Million in Commitments
  • Pulmodyne Acquiring Innovative ProductsPulmodyne Acquiring Innovative Products
  • Laborie Medical Technologies and Signet Healthcare Partners to Acquire GI SupplyLaborie Medical Technologies and Signet Healthcare Partners to Acquire GI Supply
  • Thirona Obtains AI Software Patent for Treatment of Cystic Fibrosis in ChildrenThirona Obtains AI Software Patent for Treatment of Cystic Fibrosis in Children
  • LabCorp : and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of ExcellenceLabCorp : and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence
  • Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome.Acadia Pharmaceuticals Acquires Ex-North American Rights to Trofinetide and Global Rights to Neuren’s NNZ-2591 in Rett Syndrome and Fragile X Syndrome.
  • OptimizeRx Acquires CareSpeak CommunicationsOptimizeRx Acquires CareSpeak Communications
  • Google Cloud Unveils Ai Tools to Help Healthcare Analyze Unstructured Medical TextGoogle Cloud Unveils Ai Tools to Help Healthcare Analyze Unstructured Medical Text

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications